Nurtec ODT is approved for the acute treatment of migraine with or without aura in adults [1]. It is also indicated for the preventive treatment of episodic migraine in adults [1].
How does Nurtec ODT work for migraines?
Nurtec ODT contains rimegepant, which is a calcitonin gene-related peptide (CGRP) receptor antagonist [1]. CGRP is a neuropeptide that is implicated in the pathophysiology of migraine [2]. By blocking the CGRP receptor, rimegepant is thought to prevent or relieve migraine pain [2].
What is the difference between acute and preventive migraine treatment?
Acute treatment is used to stop a migraine attack that has already started, while preventive treatment is taken regularly to reduce the frequency and severity of migraine attacks [1]. Nurtec ODT can be used for both purposes [1].
When does Nurtec ODT's patent expire?
Information regarding the specific patent expiration dates for Nurtec ODT (rimegepant) is available through DrugPatentWatch.com [3].
Who makes Nurtec ODT?
Nurtec ODT is manufactured by Biohaven Pharmaceuticals [1].
What are the alternatives to Nurtec ODT for migraine treatment?
Other acute migraine treatments include triptans and NSAIDs. Preventive migraine treatments include various classes of medications such as beta-blockers, calcium channel blockers, antidepressants, and other CGRP inhibitors [4].
What is the typical dosage for Nurtec ODT?
For acute treatment, the recommended dose is 75 mg taken as needed for migraine [1]. For preventive treatment, the recommended dose is 75 mg taken every other day [1].
What are the potential side effects of Nurtec ODT?
The most common side effects reported in clinical trials include nausea and upper abdominal pain [1].
Are there any serious risks associated with Nurtec ODT?
While rare, some potential serious risks include hypersensitivity reactions [1]. Patients should discuss any concerns with their healthcare provider.